167 related articles for article (PubMed ID: 36627049)
1. WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity.
Wei X; Wang B; Wu Z; Yang X; Guo Y; Yang Y; Fang Z; Yi C; Zhang L; Fan X; Zhang L; Song D
Cancer Lett; 2023 Mar; 556():216058. PubMed ID: 36627049
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
Yuan Y; Qi G; Shen H; Guo A; Cao F; Zhu Y; Xiao C; Chang W; Zheng S
Int J Cancer; 2019 Apr; 144(7):1584-1595. PubMed ID: 29987896
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase-mediated cross-linking of WDR54 regulates EGF receptor-signaling.
Maeda A; Nishino T; Matsunaga R; Yokoyama A; Suga H; Yagi T; Konishi H
Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):285-295. PubMed ID: 30458214
[TBL] [Abstract][Full Text] [Related]
4. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
Yoshida K; Tsuda M; Matsumoto R; Semba S; Wang L; Sugino H; Tanino M; Kondo T; Tanabe K; Tanaka S
Cancer Sci; 2019 Jul; 110(7):2119-2132. PubMed ID: 31141251
[TBL] [Abstract][Full Text] [Related]
5. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
Zhang J; Zhou Q; Xie K; Cheng L; Peng S; Xie R; Liu L; Zhang Y; Dong W; Han J; Huang M; Chen Y; Lin T; Huang J; Chen X
J Exp Clin Cancer Res; 2021 Jun; 40(1):203. PubMed ID: 34154613
[TBL] [Abstract][Full Text] [Related]
6. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.
Liu Z; Xie D; Zhang H
Cell Death Dis; 2018 Oct; 9(10):1042. PubMed ID: 30310053
[TBL] [Abstract][Full Text] [Related]
8. RAB14 activates MAPK signaling to promote bladder tumorigenesis.
Chao H; Deng L; Xu F; Fu B; Zhu Z; Dong Z; Liu YN; Zeng T
Carcinogenesis; 2019 Nov; 40(11):1341-1351. PubMed ID: 30809635
[TBL] [Abstract][Full Text] [Related]
9. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
Man X; Piao C; Lin X; Kong C; Cui X; Jiang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):259. PubMed ID: 31200745
[TBL] [Abstract][Full Text] [Related]
10. Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
Yang J; Wang B; Chen H; Chen X; Li J; Chen Y; Yuan D; Zheng S
Cell Prolif; 2019 Mar; 52(2):e12560. PubMed ID: 30515906
[TBL] [Abstract][Full Text] [Related]
11. MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells.
Sorokin AV; Chen J
Oncogene; 2013 Jun; 32(26):3130-8. PubMed ID: 22824790
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop.
Gao T; Ji Y
Urol Int; 2021; 105(9-10):891-905. PubMed ID: 34192702
[TBL] [Abstract][Full Text] [Related]
13. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
[TBL] [Abstract][Full Text] [Related]
14. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
15. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
[No Abstract] [Full Text] [Related]
16. Clinicopathological and cellular signature of PAK1 in human bladder cancer.
Huang K; Chen G; Luo J; Zhang Y; Xu G
Tumour Biol; 2015 Apr; 36(4):2359-68. PubMed ID: 25412958
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway.
Gao Y; Liu S; Guo Q; Zhang S; Zhao Y; Wang H; Li T; Gong Y; Wang Y; Zhang T; Dong Z; Bacich D; Chowdhury WH; Rodriguez R; Wang Z
Int J Biol Sci; 2019; 15(7):1488-1499. PubMed ID: 31337978
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5.
He X; Ding X; Wen D; Hou J; Ping J; He J
Pathol Res Pract; 2017 Sep; 213(9):1059-1066. PubMed ID: 28843748
[TBL] [Abstract][Full Text] [Related]
19. LncRNA
Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
[No Abstract] [Full Text] [Related]
20. Fibronectin 1 as a Key Gene in the Genesis and Progression of Cadmium-Related Bladder Cancer.
Zhang L; Wang Y; Song M; Chang A; Zhuo W; Zhu Y
Biol Trace Elem Res; 2023 Sep; 201(9):4349-4359. PubMed ID: 36471209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
